Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAM | P19021 | 1/20 | 0.68 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | CES2 | O00748 | 1/20 | 0.45 |
| ▸ | CES1 | P23141 | 1/20 | 0.45 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | CASP1 | P29466 | 1/20 | 0.45 |
| ▸ | KLK7 | P49862 | 1/20 | 0.44 |
| ▸ | MGLL | Q99685 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4947139 | 0.85 | PAM (0.72) | PAML3MBTL1ALDH1A1MAPK1KMT2A | |
| SCHEMBL4947133 | 0.81 | PAM (0.72) | PAML3MBTL1ALDH1A1MAPK1KMT2A | |
| SCHEMBL5999038 | 0.81 | PAM (0.78) | PAML3MBTL1ALDH1A1MAPK1KMT2A | |
| SCHEMBL3748732 | 0.81 | PAM (1.00) | PAML3MBTL1ALDH1A1MAPK1KMT2A | |
| SCHEMBL24487079 | 0.78 | L3MBTL1 (0.54) | PAML3MBTL1ALDH1A1MAPK1KMT2A | |
| SCHEMBL3673828 | 0.78 | PAM (0.72) | PAML3MBTL1ALDH1A1MAPK1KMT2A | |
| SCHEMBL1449153 | 0.77 | ALDH1A1 (0.68) | PAML3MBTL1ALDH1A1MAPK1KMT2A | |
| Bicarbonate SCHEMBL6989215 | 0.77 | CES1 (0.56) | L3MBTL1ALDH1A1MAPK1KMT2AMEN1 | |
| SCHEMBL1434644 | 0.77 | ALDH1A1 (0.73) | PAML3MBTL1ALDH1A1MAPK1KMT2A | |
| SCHEMBL6988546 | 0.76 | PAM (0.70) | PAML3MBTL1ALDH1A1MAPK1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11981645-B1 | N′-(2-naphthoyloxy)-2-(benzo[d]oxazol-2-yl)acetimidamide as antimicrobial compound | King Faisal University (SA) | 2024-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11981645-B1 | N′-(2-naphthoyloxy)-2-(benzo[d]oxazol-2-yl)acetimidamide as antimicrobial compound | NOC2L, NIT2, NAALAD2 | PAM 34/4885L3MBTL1 2583/4885ALDH1A1 1519/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.